Court Rules in Favor of Plaintiffs in Trademark Infringement Case

Background

In a significant ruling on November 13, 2024, the Delhi High Court addressed a trademark infringement case involving plaintiffs Zydus Healthcare Ltd. and its subsidiaries against Alder Biochem Pvt. Ltd. The plaintiffs sought an interim injunction to prevent the defendant from using the mark 'ALDER BIOCHEM', claiming it infringed upon their registered trademark 'BIOCHEM', which has been in use since 1959.

Arguments

The plaintiffs argued that the defendant's mark was visually and phonetically similar to their trademark, leading to potential confusion among consumers in the pharmaceutical market. They emphasized that 'BIOCHEM' has acquired significant goodwill and reputation over the years, and the defendant's adoption of a similar mark was a deliberate attempt to exploit this reputation for financial gain.

Conversely, the defendant contended that 'BIOCHEM' is a generic term commonly used in the pharmaceutical industry, asserting that they had been using the mark 'ALDER BIOCHEM' since 2016. They argued that the plaintiffs did not have exclusive rights to the term 'BIOCHEM' and that their use of the mark was in accordance with honest trade practices.

Court's Analysis and Reasoning

The court analyzed the arguments presented by both parties, focusing on the likelihood of confusion among consumers. It noted that the plaintiffs had established prior use of the mark 'BIOCHEM' and that the defendant's mark was deceptively similar, despite the addition of the prefix 'ALDER'. The court referenced previous case law, emphasizing that the dominant features of a trademark are crucial in determining infringement.

The court found that the defendant's use of 'ALDER BIOCHEM' was likely to cause confusion, as both marks were used in relation to similar pharmaceutical products. The court also highlighted that the plaintiffs had provided substantial evidence of their sales figures and the reputation of their trademark, further supporting their claim.

Decision

Ultimately, the court granted the plaintiffs' request for an interim injunction, restraining the defendant from using the mark 'ALDER BIOCHEM' and any similar marks. The ruling underscores the importance of protecting established trademarks in the pharmaceutical industry, where confusion can have serious implications for consumer safety. The court's decision serves as a reminder of the legal protections afforded to trademark owners against infringement and deceptive practices.